This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?
by Zacks Equity Research
Sector ETF report for PTH
5 ETF Areas for Investors to Consider Amid the September Slump
by Sweta Jaiswal, FRM
Amid the market uncertainty, we have highlighted some ETF areas that can be good investment options for market participants to combat the September chaos.
Should You Invest in the ALPS Medical Breakthroughs ETF (SBIO)?
by Zacks Equity Research
Sector ETF report for SBIO
5 ETFs to Combat Stimulus Tapering Concerns, Virus Woes
by Sweta Jaiswal, FRM
Here we discuss some ETFs that seem like good additions to the portfolio given that the present market scenario is largely dominated by Fed's stimulus tapering concerns.
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
'Animal Spirits' Show There Feathers
by Daniel Laboe
An elevated level of new daily 52-week highs and lows exemplify a polarizing stock market with an equal mix of hope and fear
5 Hot Equity ETFs of Last Week Amid Volatility
by Sweta Killa
ETFs overall gathered about $18 billion capital last week (Aug 16-19), bringing in inflows of $563.2 billion year to date.
5 ETFs to Bet on Fed's Stimulus Tapering Concerns, Weak Data
by Sweta Jaiswal, FRM
Here we discuss some ETFs that seem like a good addition to the portfolio considering the present market scenario largely dominated by Fed's tapering concerns.
Healthcare ETF (XLV) Hits a New 52-Week High
by Sweta Jaiswal, FRM
The Health Care Select Sector SPDR Fund (XLV) hits a new 52-week high. Are more gains in store?
The Zacks Analyst Blog Highlights: KBE, XMVM, XLB, XLV and PFM
by Zacks Equity Research
The Zacks Analyst Blog Highlights: KBE, XMVM, XLB, XLV and PFM